文献速递运动医学关节外科

血小板浓度不影响肩袖修复PRP辅助的临床疗效与再撕裂率

Platelet Concentration Does Not Influence Clinical Efficacy and Retear Rates of Rotator Cuff Repair With Platelet-Rich Plasma: A Systematic Review and Meta-analysis With Meta-Regression.
PubMed 文献 · Am J Sports Med · 2026-04-07

系统综述与Meta分析纳入10项1-2级研究共696例患者(PRP组346例,对照组350例),比较高低剂量PRP辅助肩袖修复的疗效。Meta分析和Meta回归均显示,不同血小板浓度组在患者报告结局和再撕裂率上无显著差异(均P > .05)。

要点

  • PRP血小板浓度高低不影响肩袖修复术后临床评分和再撕裂率。
  • 高剂量PRP定义为血小板浓度较全血增加>4倍。
  • 需进一步规范报告PRP制备与成分以确认临床应用价值。

核心结论

  • 血小板浓度可能不影响接受PRP辅助肩袖修复患者的临床结局和再撕裂率。

研究设计与样本

  • 系统综述与Meta分析,证据等级2级,检索PubMed、Cochrane Library和Embase数据库。
  • 纳入10项1级或2级研究,共696例患者(PRP组346例,对照组350例),平均年龄54.3岁,平均随访25.7个月。
  • 根据血小板浓度因子较全血增加>4倍将PRP分为高剂量和低剂量,6项研究使用低剂量PRP,4项使用高剂量PRP。

主要发现

  • Meta分析和Meta回归分析均显示,不同血小板剂量组间所有患者报告结局的平均术后评分无显著差异(均P > .05)。
  • 不同血小板剂量组间平均再撕裂率无显著差异(均P > .05)。

关键数值与推荐

  • 高剂量PRP定义为血小板浓度因子较全血增加>4倍。
  • 评估结局包括视觉模拟评分、Constant-Murley评分、美国肩肘外科医师评分和加州大学洛杉矶分校评分的标准化均数差,以及再撕裂率的合并比值比。

临床怎么用

  • 临床中PRP辅助肩袖修复时,血小板浓度高低可能不影响疗效和再撕裂率,选择PRP时可综合考虑其他因素。
  • 需进一步研究充分报告PRP制备程序和成分,以增强对PRP辅助肩袖修复临床应用和疗效的信心。

局限性

  • 需要进一步研究充分报告PRP程序和成分,以确认其临床应用和疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Platelet-rich plasma (PRP) is emerging as a popular augmentation technique in the context of rotator cuff repair (RCR) to strengthen the repair construct and promote healing. Previous studies examining the efficacy of PRP augmentation during RCR have described heterogeneous results. PURPOSE: To determine whether platelet concentration of a PRP injection as an adjunct of RCR impacts clinical outcomes and retear rates. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 2. METHODS: A systematic review was performed by searching the PubMed, Cochrane Library, and Embase databases to identify level 1 and 2 studies that evaluated the clinical efficacy of RCR augmented with PRP. The search phrase used was "rotator cuff repair AND (PRP OR platelet rich plasma OR platelet-rich plasma)." Included randomized controlled trials were classified as utilizing high-dose or low-dose PRP based on their platelet concentration factor as a >4-fold increase over whole blood. The outcomes evaluated were the standardized mean differences of visual analog scale scores, Constant-Murley scores, American Shoulder and Elbow Surgeons scores, and University of California-Los Angeles scores, and pooled odds ratios of retear rates. Mixed-effects and random-effects meta-analyses were performed along with meta-regression to evaluate relationships in patient outcomes associated with PRP platelet dose. RESULTS: Ten studies (level 1 or 2) met inclusion criteria, including 696 patients (346 PRP, 350 control). The mean patient age at the time of repair was 54.3 years, and the mean follow-up time was 25.7 months. Of the 10 studies, 6 utilized low-dose PRP and 4 utilized high-dose PRP. In both the meta-analysis and meta-regression analyses, there were no significant differences in mean postoperative scores for all patient-reported outcomes or in mean retear rates between platelet dosage groups (all P > .05). CONCLUSION: Platelet concentration may not influence the clinical outcomes and retear rates of patients undergoing RCR with PRP augmentation. Further studies that adequately report PRP procedures and composition regarding PRP as an RCR augmentation are necessary to achieve confidence in their clinical application and efficacy.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Lim JJ, Stepaniuk EA, Belk JW, et al. Platelet Concentration Does Not Influence Clinical Efficacy and Retear Rates of Rotator Cuff Repair With Platelet-Rich Plasma: A Systematic Review and Meta-analysis With Meta-Regression. Am J Sports Med. 2026. PMID: 41947497. doi:10.1177/03635465261434001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。